Tuttiquotidiani is completely free. Every day we aggregate news from 100+ sources and generate original AI summaries for you. Help us keep the service running with a small donation, or become TQ Pro for just €1/month.

Donate now TQ Pro - 1€/mo

UK's AstraZeneca eyeing $400b merger, report says

Posted on August 4, 2026
By The China Daily
0 Views
1 min read

In brief

Generating AI summary…

UK's AstraZeneca eyeing $400b merger, report says

The United Kingdom's second-most valuable listed company, pharmaceutical firm AstraZeneca, has been revealed to have been holding talks for some time with United States-based rival Bristol Myers Squibb, or BMS, about a merger, which could result in a global pharma giant worth nearly $400 billion.